• Citer

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial

par Curigliano, Giuseppe;O'Shaughnessy, Joyce;Bidard, François-Clément;Casalnuovo, Monica Lis;Kim, Sung-Bae;Tokunaga, Eriko;Aftimos, Philippe ;Saura, Cristina;Carey, Lisa L.A.;Okera, Meena;Melo, E.;Zagouri, Flora;Magallanes-Maciel, Manuel Ernesto M.;Karadurmus, Nuri;Bahadur, Shakeela;Speck, Rebecca R.M.;Wang, Xuejing Aimee;Pradhan, Kamnesh K.R.;Macey, Jake;Kitchen, Helen;Fairhurst, S.;Miller, Jordan;Jhaveri, Komal K.L.;Harbeck, Nadia
Référence ESMO Open, 11, 4, 106945
Publication Publié, 2026-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial
Auteur:	Curigliano, Giuseppe; O'Shaughnessy, Joyce; Bidard, François-Clément; Casalnuovo, Monica Lis; Kim, Sung-Bae; Tokunaga, Eriko; Aftimos, Philippe; Saura, Cristina; Carey, Lisa L.A.; Okera, Meena; Melo, E.; Zagouri, Flora; Magallanes-Maciel, Manuel Ernesto M.; Karadurmus, Nuri; Bahadur, Shakeela; Speck, Rebecca R.M.; Wang, Xuejing Aimee; Pradhan, Kamnesh K.R.; Macey, Jake; Kitchen, Helen; Fairhurst, S.; Miller, Jordan; Jhaveri, Komal K.L.; Harbeck, Nadia
Informations sur la publication:	ESMO Open, 11, 4, 106945
Statut de publication:	Publié, 2026-04
Sujet CREF:	Cancérologie
Mots-clés:	advanced breast cancer
	ESR1 mutations
	imlunestrant
	oral selective estrogen receptor degraders (SERDs)
	patient-reported outcomes
	quality of life
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2059-7029
	info:doi/10.1016/j.esmoop.2026.106945
	info:pii/S2059702926008872
	info:scp/105035121533
	info:pmid/41962306